Media coverage
18
Media coverage
Title Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel™ (CBD Gel) in Fragile X Syndrome Media name/outlet Morningstar.com Country/Territory United States Date 06/30/20 URL https://www.morningstar.com/news/globe-newswire/7952695/zynerba-pharmaceuticals-announces-top-line-results-from-pivotal-connect-fx-trial-of-zygel-cbd-gel-in-fragile-x-syndrome Persons William Roberts Title Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel™ (CBD Gel) in Fragile X Syndrome Media name/outlet Yahoo! Finanzas Country/Territory United States Date 06/30/20 URL https://es-us.finanzas.yahoo.com/news/zynerba-pharmaceuticals-announces-top-line-104510856.html Persons William Roberts Title Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel™ (CBD Gel) in Fragile X Syndrome Media name/outlet MarketScreener.com Country/Territory United States Date 06/30/20 URL https://www.marketscreener.com/ZYNERBA-PHARMACEUTICALS-23277306/news/Zynerba-Pharmaceuticals-Announces-Top-Line-Results-from-Pivotal-CONNECT-FX-Trial-of-Zygel-trade-CB-30847877/ Persons William Roberts Title Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel™ (CBD Gel) in Fragile X Syndrome Media name/outlet MarketScreener.com Country/Territory United States Date 06/30/20 URL https://www.marketscreener.com/ZYNERBA-PHARMACEUTICALS-23277306/news/Zynerba-Pharmaceuticals-Announces-Top-Line-Results-from-Pivotal-CONNECT-FX-Trial-of-Zygel-trade-CB-30847877/?utm_medium=RSS&utm_content=20200630 Persons William Roberts Title Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel (CBD Gel) in Fragile X Syndrome Media name/outlet Wallstreet Online Country/Territory Germany Date 06/30/20 URL https://www.wallstreet-online.de/nachricht/12674152-zynerba-pharmaceuticals-announces-top-line-results-from-pivotal-connect-fx-trial-of-zygel-cbd-gel-fragile-x-syndrome Persons William Roberts Title Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel™ (CBD Gel) in Fragile X Syndrome Media name/outlet Market Newsdesk Country/Territory United States Date 06/30/20 URL www.marketnewsdesk.com/?p=294250 Persons William Roberts Title Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel ™ (CBD Gel) in Fragile X Syndrome Media name/outlet Stockwatch Country/Territory Canada Date 06/30/20 URL www.stockwatch.com/News/Item?bid=U-z7952695-U%3aZYNE-20200630&symbol=ZYNE®ion=U Persons William Roberts Title Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel(TM) (CBD Gel) in Fragile X Syndrome Media name/outlet TD Ameritrade Country/Territory United States Date 06/30/20 URL https://research.tdameritrade.com/grid/public/markets/news/story.asp?fromPage=results&docKey=100-182u6606 Persons William Roberts Title Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel™ (CBD Gel) in Fragile X Syndrome Media name/outlet Crwe World Country/Territory United States Date 06/30/20 URL crweworld.com/article/news-provided-by-globenewswire/1590188/zynerba-pharmaceuticals-announces-top-line-results-from-pivotal-connect-fx-trial-of-zygelcbd-gel-in-fragile-x-syndrome Persons William Roberts Title Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel™ (CBD Gel) in Fragile X Syndrome Media name/outlet Zynerba Country/Territory United States Date 06/30/20 URL https://zynerba.com/zynerba-pharmaceuticals-announces-top-line-results-from-pivotal-connect-fx-trial-of-zygel-cbd-gel-in-fragile-x-syndrome/ Persons William Roberts Title Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel™ (CBD Gel) in Fragile X Syndrome Media name/outlet Zynerba Country/Territory United States Date 06/30/20 URL https://zynerba.com/zynerba-pharmaceuticals-announces-top-line-results-from-pivotal-connect-fx-trial-of-zygel-cbd-gel-in-fragile-x-syndrome/ Persons William Roberts Title Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel™ (CBD Gel) in Fragile X Syndrome Media name/outlet Jotup Country/Territory United States Date 06/30/20 URL https://jotup.co/node/841213 Persons William Roberts Title Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel™ (CBD Gel) in Fragile X Syndrome Media name/outlet BioSpace Country/Territory United States Date 06/30/20 URL https://www.biospace.com/article/releases/zynerba-pharmaceuticals-announces-top-line-results-from-pivotal-connect-fx-trial-of-zygel-cbd-gel-in-fragile-x-syndrome/?s=86 Persons William Roberts Title Top Line Results from Pivotal CONNECT FX Trial of Zygel(TM) (CBD Gel) in Fragile X Syndrome Media name/outlet Market News Publishing Country/Territory United States Date 06/30/20 Persons William Roberts Title Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel™ (CBD Gel) in Fragile X Syndrome Media name/outlet GlobeNewswire Country/Territory United States Date 06/30/20 URL https://www.globenewswire.com/news-release/2020/06/30/2055273/0/en/Zynerba-Pharmaceuticals-Announces-Top-Line-Results-from-Pivotal-CONNECT-FX-Trial-of-Zygel-CBD-Gel-in-Fragile-X-Syndrome.html Persons William Roberts Title Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel™ (CBD Gel) in Fragile X Syndrome Media name/outlet GlobeNewswire Country/Territory United States Date 06/30/20 URL www.globenewswire.com/news-release/2020/06/30/2055273/0/en/Zynerba-Pharmaceuticals-Announces-Top-Line-Results-from-Pivotal-CONNECT-FX-Trial-of-Zygel-CBD-Gel-in-Fragile-X-Syndrome.html Persons William Roberts Title Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel™ (CBD Gel) in Fragile X Syndrome Media name/outlet EIN Presswire Country/Territory United States Date 06/30/20 URL https://www.einpresswire.com/article/520643619/zynerba-pharmaceuticals-announces-top-line-results-from-pivotal-connect-fx-trial-of-zygel-cbd-gel-in-fragile-x-syndrome Persons William Roberts Title Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel™ (CBD Gel) in Fragile X Syndrome Media name/outlet BizWire Express Country/Territory India Date 06/30/20 URL www.bizwireexpress.com/showstoryGNW.php?storyid=26998 Persons William Roberts